Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):94–101. doi: 10.1097/QAI.0000000000000816

Table 4.

Associations between frequent CAI (> 1 time/week) and preferences for PrEP dosing

PrEP dosing Bivariate Models Multivariable Models1
OR (95% CI) P aOR (95% CI) P
Daily PrEP 1.39 (1.08 to 1.79) 0.01 1.49 (1.13 to 1.91) 0.004
Event-driven PrEP2 0.71 (0.54 to 0.94) 0.02 0.76 (0.57 to 1.02) 0.065
Time-driven PrEP3 0.94 (0.73 to 1.22) 0.65 0.98 (0.75 to 1.27) 0.87
1

Adjusted for age, education (college grad or above versus less than), income, sexual orientation, in a monogamous relationship, depression, problematic alcohol use, having visited a provider in the past 12 months, and nation of residence (United States or Canada);

2

Defined as having to take a pill right before sex and soon after for it to work;

3

Defined as having to take a pill every Monday and Friday plus another pill soon after sex for it to work